<div id="readability-page-1"><p>Altria ((MO)) has held its Q1 earnings call. Read on for the main highlights of the call.</p><h3>Claim 55% Off TipRanks</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Discover top-performing stock ideas and upgrade to a portfolio of market leaders with  Smart Investor Picks  </li></ul> <p>Altria’s latest earnings call painted a cautiously optimistic picture, with strong per‑share earnings growth and robust cash returns to investors offset by clear volume and share pressures in both cigarettes and oral tobacco. Management highlighted disciplined pricing, expanding smokeable margins and growing pouch shipments, but also stressed macroeconomic uncertainty and the drag from illicit e‑vapor products.</p> <h2>Adjusted EPS Growth Signals Solid Start</h2> <p>Adjusted diluted EPS rose 7.3% versus Q1 2025, setting a strong tone for the year and outpacing the company’s full‑year growth target. Management framed this performance as evidence of resilient profitability despite volume declines, supported by pricing power and cost control across the portfolio.</p> <h2>Smokeable Margins Edge Higher</h2> <p>In the smokeable segment, adjusted operating company income increased 6.3% and margins expanded to 65.1%, up 0.7 percentage points. Net price realization of 6.3% helped offset lower volumes, underscoring Altria’s ability to defend profitability even as cigarette consumption trends remain negative.</p> <h2>on! Pouch Shipments and on! PLUS Rollout</h2> <p>Total on! portfolio shipments grew nearly 18% to more than 46 million cans in Q1, underscoring strong consumer uptake of nicotine pouches. The new on! PLUS line began nationwide shipping in March and reached about 100,000 stores by quarter‑end, stores that represent roughly 85% of category volume.</p> <h2>Helix Execution Strengthens Retail Presence</h2> <p>Helix’s trade program secured premium shelf positioning in contracted outlets covering around 90% of Helix volume, bolstering visibility for on! and on! PLUS. Together these brands captured 7.8% of the total oral‑tobacco category, adding 0.2 share points sequentially despite broader category and volume pressures.</p> <h2>Signs of Stabilization in E‑Vapor Market</h2> <p>Altria estimated about 20.5 million adult vapors, essentially flat year over year, hinting at a maturing user base. Management pointed to moderating growth in illicit flavored disposable products due to stepped‑up enforcement and supply disruptions, suggesting the early stages of category stabilization.</p> <h2>ABI Earnings and Shareholder Returns</h2> <p>Equity earnings from Altria’s stake in ABI climbed 9.6% year over year to $160 million, providing a meaningful income stream alongside core operations. The company returned significant capital, paying roughly $1.8 billion in dividends and repurchasing 4.5 million shares for $280 million during the quarter.</p> <h2>Balance Sheet Deleveraging on Track</h2> <p>Altria retired just over $1 billion of maturing debt in February, bringing total debt‑to‑EBITDA to 1.9 times and keeping leverage aligned with internal targets. The company ended the quarter with about $72 million remaining under its current share repurchase authorization, signaling continued flexibility for capital returns.</p> <h2>Oral Tobacco Volumes and Share Under Pressure</h2> <p>Total oral‑tobacco shipment volume fell 3.1% in Q1 and, after adjusting for trade inventory moves, management estimated an 8.5% decline. Retail share for the segment dropped 5.5 percentage points year over year, highlighting competitive pressures and shifting consumer dynamics within modern oral products.</p> <h2>Margin Compression in Oral Tobacco</h2> <p>While oral‑tobacco adjusted OCI surpassed $400 million, margins slipped to 67.4%, down 1.8 percentage points from a year earlier. The decline reflected heavier marketing investment behind Helix and mix pressure between traditional moist snuff and higher‑growth nicotine pouches.</p> <h2>Cigarette Volumes Continue to Decline</h2> <p>Reported domestic cigarette shipments fell 2.4% in the quarter, and adjusted volumes were down about 4% after accounting for trade inventory changes. Management noted that industry‑wide adjusted volumes declined roughly 5%, suggesting Altria continues to perform slightly better than the broader cigarette market.</p> <h2>Marlboro Retail Share Erodes</h2> <p>Marlboro’s overall retail share contracted by 1.4 percentage points year over year, with a modest 0.1‑point decline sequentially. The company cited increased consumer trade down to value brands as a key factor, underscoring the pressure on premium labels in a strained macro environment.</p> <h2>Discount Brands Benefit From Trade‑Down</h2> <p>The discount segment’s retail share expanded by 2.4 percentage points year over year as budget‑conscious smokers shifted away from premium offerings. Altria’s Basic brand capitalized on this trend, with its retail share climbing 0.5 percentage points sequentially and 2.4 points versus the prior year.</p> <h2>Persistent Challenges in E‑Vapor Category</h2> <p>Despite some enforcement gains, Altria reported that about 70% of the e‑vapor category still consists of illicit flavored disposable products. Management argued that the limited roster of authorized products is constraining the development of a fully compliant market and limiting the harm‑reduction potential of regulated alternatives.</p> <h2>Guidance Reaffirmed Amid Macro Uncertainty</h2> <p>Altria reaffirmed its 2026 full‑year adjusted EPS outlook of $5.56 to $5.72, implying 2.5% to 5.5% growth from a $5.42 base, and expects a more balanced earnings cadence after a strong Q1. The guidance already assumes slower combustible and e‑vapor volume trends and a challenging macro backdrop, while maintaining a focus on dividends, buybacks and a disciplined balance‑sheet posture.</p> <p>Altria’s call underscored a business still generating strong cash and expanding key margins, but increasingly reliant on pricing and productivity to offset shrinking volumes and category shifts. Investors heard a mix of confidence in smokeable profitability and pouch growth and caution around regulatory risk, illicit vapor products and consumer trade‑down, leaving the outlook steady but far from complacent.</p></div>

<p>Altria's Q1 earnings call revealed a cautiously optimistic outlook, with a 7.3% rise in adjusted EPS despite volume declines in cigarettes and oral tobacco. Management highlighted strong cash returns and disciplined pricing, while acknowledging macroeconomic uncertainties and pressures from illicit e-vapor products. The company reaffirmed its 2026 EPS guidance of $5.56 to $5.72, anticipating slower volume trends. Notably, Altria's equity earnings from ABI rose 9.6%, and it returned $1.8 billion to shareholders through dividends and share repurchases.</p>

Altria Earnings Call Balances Strength With Caution